Skip to main content
logo
Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.780
+0.170 (10.56%)
At close: Nov 6, 2026, 4:00 PM EST
1.780
0.00 (0.00%)
After-hours: Nov 6, 2026, 7:59 PM EST

Lexicon Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-50.34-200.4-177.12-101.94-87.76
Depreciation & Amortization
0.620.530.550.430.29
Other Amortization
1.71.851.770.740.05
Loss (Gain) From Sale of Assets
---00.05
Loss (Gain) From Sale of Investments
-3.71-9.31-5.62--
Stock-Based Compensation
12.5213.514.3411.5210.58
Other Operating Activities
-1.740.811.51--
Change in Accounts Receivable
1.09-2.46-0.98-0.010.38
Change in Inventory
-0.050.15-0.38--
Change in Accounts Payable
-30.2214.86.450.08-14.16
Change in Other Net Operating Assets
2.291.75-2.430.343.55
Operating Cash Flow
-67.85-178.78-161.9-88.85-87.02
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--1.03-0.47-1.33-1.22
Investment in Securities
113.02-14.35-49.47-69.753.33
Investing Cash Flow
113.02-15.38-49.94-71.082.11

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--49.9648.87-
Long-Term Debt Repaid
-48----11.7
Net Debt Issued (Repaid)
-48-49.9648.87-11.7
Issuance of Common Stock
0.070.06138.8294.2137.08
Repurchase of Common Stock
-0.57-1.73-0.82-0.86-2.68
Other Financing Activities
--1.31---
Financing Cash Flow
-48.5238.35187.96142.2122.71

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-3.3344.19-23.88-17.72-62.2

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-67.85-179.81-162.37-90.18-88.24
Free Cash Flow Growth
-----
Free Cash Flow Margin
-136.24%-578.52%-13485.63%-64875.54%-29610.07%
Free Cash Flow Per Share
-0.19-0.56-0.73-0.54-0.61
Levered Free Cash Flow
-47.82-105.3-94.97-52.65-55.54
Unlevered Free Cash Flow
-44.3-97.41-88.56-51.65-55.09

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
8.3312.9210.062.290.8
Change in Working Capital
-26.8914.242.660.4-10.23
SEC Filings: 10-K · 10-Q